America's strong intellectual property (IP) system provides crucial incentives for innovation and helps advance the development of new medicines. But world leaders are considering a harmful and unnecessary proposal to weaken IP rights for developers of new COVID-19 treatments and diagnostics, which could hamper U.S. innovation, threaten American jobs, and jeopardize our ability to respond to future pandemics.
